Investors Once Eyeing FLOKI (FLOKI) And Injective (INJ), Have Sights Set On Hybrid-Exchange Tradecurve (TCRV)

FLOKI (FLOKI), Injective (INJ), and Tradecurve.io have been some of the most discussed cryptocurrencies across investor circles throughout the week. However, none are equalling the momentum seen by Tradecurve, whilst all have managed to gain equal gains regarding their value and overall appeal Tradecurve’s presale firmly stands head and shoulders above the competition.

binance coins towers people looking up stacks growing expanding

FLOKI (FLOKI), Injective (INJ), and Tradecurve.io have been some of the most discussed cryptocurrencies across investor circles throughout the week. However, none are equalling the momentum seen by Tradecurve, whilst all have managed to gain equal gains regarding their value and overall appeal Tradecurve’s presale firmly stands head and shoulders above the competition.

Today, we will go over all three projects to see why we believe each can be the perfect fit for a cryptocurrency trader’s portfolio.

Sponsored

BUY TRADECURVE TOKENS

FLOKI (FLOKI)

FLOKI (FLOKI) has seen a massive level of momentum within the previous 30 days due to the most recent listing on a major exchange.

Specifically, Binance.US listed FLOKI (FLOKI) on the platform. 

This essentially means that FLOKI (FLOKI) is now a part of the most popular meme-inspired cryptocurrencies on the platform.

As for its value, as of April 25, 2023, FLOKI (FLOKI) trades at a value of $0.00003557. In the last 24 hours, FLOKI (FLOKI) increased in value by 3.2%. However, in the previous seven days, FLOKI (FLOKI) is still down by 5.7%. Aside from FLOKI (FLOKI), investors are eyeing two other altcoins.

Injective (INJ)

There was a huge announcement made on top of the Injective (INJ) Twitter page that took the community by storm. Celer Network has integrated Injective (INJ). The goal of this integration is to initially bring novel assets to the ecosystem.

Injective (INJ) will now provide one of the highest cross-chain connections within the industry. 

As of April 25, 2023, Injective (INJ) was trading at $7.25. In the last 24 hours, Injective (INJ) grew in value by 8.3%. Injective (INJ) has decreased by 19.3% in the last seven days. However, within the previous 30 days, Injective (INJ) has been on a bullish run, increasing by 88.6%.

Tradecurve (TCRV) the next 50x token?

Tradecurve.io is a hybrid exchange built on the Ethereum blockchain, the Tradecurve platform combines the best elements of Centralized and Decentralized exchanges. Tradecurve provides users with a platform from which they can begin trading; cryptocurrencies, stocks, forex, and commodities all without needing to complete a KYC procedure.

Customers to the Tradecurve platform simply submit their email address, connect a DeFi wallet, deposit a cryptocurrency of their choosing and instantly begin trading.

Tradecurve also has several notable features including high leverage, algorithmic trading, VIP account services, a Metaverse Trading Academy, and negative balance protection.

Holders of the Tradecurve native utility token $TCRV can utilize, Copy Trading, automated trading, passive income from staking tokens, and lower subscription and trading fees.

Tradecurve’s token smart contract has been fully audited by CyberScope to provide transparency and clarity throughout the project. Currently at the stage one presale, the Tradecurve native utility token $TCRV is trading at $0.01. 

Tradecurve’s development team has stated that all team tokens will be locked for three years, whilst the liquidity pool will be locked for two years. Analysts predict that Tradecurve will shatter previous presale records and surpass 100x in value when the project launches.

For more information regarding the Tradecurve presale see the links below: 

Buy presale: https://app.tradecurve.io/sign-up 

Website: https://tradecurve.io/ 

Twitter: https://twitter.com/Tradecurveapp 

Telegram: https://t.me/tradecurve_official 

This article contains a press release from an external source. The opinions and information presented may differ from those of DailyCoin. Readers are encouraged to independently verify the details and consult with experts before acting on any information provided. Please note that our Terms and Conditions, Privacy Policy, and Risk Warning have been recently updated.

This article is for information purposes only and should not be considered trading or investment advice. Nothing herein shall be construed as financial, legal, or tax advice. Trading forex, cryptocurrencies, and CFDs pose a considerable risk of loss.

Author
Press Release

Read the most recent crypto press releases on DailyCoin to know all the latest project news from fintech and blockchain businesses. Disclaimer: This article is a press release and was not written by DailyCoin. We always aim to have the highest editorial and fact-checking standards, so if you encounter any content related issues, please contact us at pr@dailycoin.com.